Jonathan Yong

Stock Analyst at UBS

(2.60)
# 2,259
Out of 5,030 analysts
97
Total ratings
60.38%
Success rate
11.08%
Average return

Stocks Rated by Jonathan Yong

eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7$5
Current: $4.77
Upside: +4.82%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5$3
Current: $2.71
Upside: +10.70%
Oscar Health
Jul 15, 2025
Downgrades: Sell
Price Target: $15$11
Current: $19.39
Upside: -43.27%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33$25
Current: $28.00
Upside: -10.71%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15$12
Current: $8.06
Upside: +48.88%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7$8
Current: $3.83
Upside: +108.88%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27$26
Current: $12.63
Upside: +105.86%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $49.78
Upside: -71.88%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $62.98
Upside: +52.43%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29$32
Current: $13.39
Upside: +138.98%
Maintains: Outperform
Price Target: $115$105
Current: $19.67
Upside: +433.81%
Maintains: Outperform
Price Target: $76$80
Current: $124.55
Upside: -35.77%
Maintains: Outperform
Price Target: $247$231
Current: $285.94
Upside: -19.21%
Reiterates: Neutral
Price Target: $27
Current: $8.53
Upside: +216.53%
Maintains: Neutral
Price Target: $90$100
Current: $156.41
Upside: -36.07%
Maintains: Outperform
Price Target: $430$450
Current: $786.00
Upside: -42.75%
Maintains: Neutral
Price Target: $15$12
Current: $2.87
Upside: +318.12%
Maintains: Neutral
Price Target: $80$70
Current: $5.45
Upside: +1,184.40%
Maintains: Neutral
Price Target: $14$17
Current: $16.35
Upside: +3.98%
Maintains: Outperform
Price Target: $347$350
Current: $192.68
Upside: +81.65%
Maintains: Outperform
Price Target: $93$95
Current: $24.17
Upside: +293.13%
Maintains: Underperform
Price Target: $7$8.5
Current: $4.40
Upside: +93.18%
Reiterates: Outperform
Price Target: $41
Current: $25.53
Upside: +60.60%
Maintains: Neutral
Price Target: $20$17
Current: $4.80
Upside: +254.17%
Maintains: Neutral
Price Target: $3.3$8.5
Current: $3.08
Upside: +175.97%
Reiterates: Outperform
Price Target: $85
Current: $82.29
Upside: +3.29%
Maintains: Neutral
Price Target: $143$146
Current: $189.51
Upside: -22.96%
Maintains: Outperform
Price Target: $104$106
Current: $35.27
Upside: +200.54%
Maintains: Outperform
Price Target: $129$157
Current: $204.56
Upside: -23.25%
Maintains: Outperform
Price Target: $329$368
Current: $299.27
Upside: +22.97%
Maintains: Outperform
Price Target: $548$635
Current: $275.01
Upside: +130.90%
Maintains: Outperform
Price Target: $113$117
Current: $82.52
Upside: +41.78%
Maintains: Outperform
Price Target: $31$30
Current: $16.45
Upside: +82.37%
Maintains: Outperform
Price Target: $267$298
Current: $426.16
Upside: -30.07%
Maintains: Outperform
Price Target: $88$95
Current: $200.00
Upside: -52.50%
Maintains: Outperform
Price Target: $462$495
Current: $356.60
Upside: +38.81%